Abstract
Presented at the ASHP Midyear Clinical Meeting. December 2023.
This project evaluated the appropriateness of interleukin (IL)-17 and IL-23 inhibitor usage within Parkview Health, in both inpatient and outpatient settings.
Document Type
Poster
Publication Date
12-2023
Recommended Citation
Uetrecht, Corey PharmD Candidate; Beckett, Robert D. , PharmD, BCPS; Baumgartner, Kevin PharmD; and Sposito, Jennifer PharmD, "Medication Use Evaluation of IL-17 and IL-23 inhibitors at a Large Health System." (2023). Parkview Pharmacy Department. 87.
https://researchrepository.parkviewhealth.org/pharma/87
